Semaglutide 20 mg — Research Peptide
Semaglutide is the most established GLP-1 receptor agonist research peptide with a weekly half-life (~7 days) and strong cardiovascular research data.
Product Details
- Net weight: 20 mg (lyophilised)
- Purity: ≥98.9% (HPLC-verified)
- Identity confirmed by LC-MS
- Batch-specific COA included
For research purposes only. Not intended for human use.



Reviews
There are no reviews yet.